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Background: Ischemicpreconditioning(IPC) canprovideadefenseagainst ischemiaereperfusion
(IR)-induced acute inflammation and barrier dysfunction inmany organs. Because nitric oxide
(NO) has been implicated as a trigger or mediator in the IPCmechanism and because neuronal
NO synthase (nNOS) is a dominant isoform of NOS in the gastrointestinal tract, our aimwas to
investigate the role of nNOS in IPC-induced protection after mesenteric IR.
Materials and methods: Intestinal IR was induced in sodium pentobarbitaleanesthetized
dogs by clamping the superior mesenteric artery for 60 min followed by 2 h of reperfu-
sion (IR group; n ¼ 7). In further groups, IPC was used (three cycles of 5-min ischemia/5-min
reperfusion periods) before IR in the presence or absence of selective inhibition of nNOS
with 7-nitroindazole (5 mg/kg, intravenously, in a bolus 15 min before IPC, n ¼ 6 each).
Changes in mesenteric vascular resistance, intramucosal pH (pHi), and small bowel
motility were monitored. Plasma nitrite/nitrate levels, intestinal NO synthase activity,
leukocyte accumulation, mast cell degranulation, and histologic injury were also
determined.
Results: Ischemia significantly decreased mesenteric vascular resistance and pHi, whereas
IR induced a temporary bowel hypermotility and acute inflammatory reaction. IPC facili-
tated pHi recovery, attenuated motility dysfunction, elevated NOS-dependent NO pro-
duction, and reduced leukocyte accumulation, mast cell degranulation, and mucosal
injury. Pretreatment with 7-nitroindazole halted the IPC-induced increase in NO avail-
ability, pHi recovery, and the anti-inflammatory and morphologic effects.
Conclusions: Our data demonstrate that NO generated by intestinal nNOS plays a pivotal
role in IPC-linked tissue protection by inhibiting an IR-related acute inflammatory
response.
ª 2019 Published by Elsevier Inc.Research, University of Szeged, Pulz u. 1, H-6724 Szeged, Hungary. Tel.: þ36-62 545-103; fax:
-szeged.hu (A. Szabo´).
shed by Elsevier Inc.
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conditioning (IPC) has been demonstrated in a number of or-
gans, including the gastrointestinal tract.1-3 The attenuating
effect of IPC against an ischemiaereperfusion (IR)-induced
inflammatory response in the intestine4 involves reduced
activation of transcription factor nuclear factor-kappa bind-
ing5 and cytoprotection through inhibition of apoptosis.6
Preservation of enteric nerve function and prevention of in-
testinal motility dysfunction represent another manifest
protective effect of IPC, at least in rats.7
Among many possible triggers and mediators, nitric oxide
(NO) seems to play a key initiating role in IPC-linked protec-
tion. This hypothesis is supported by the immediate increase
in tissue nitrite and nitrate (NOx) levels after IPC in the rat
intestine.2 It has also been shown that endogenous NO pro-
duction by NO synthases (NOSs) plays a regulatory role in
intestinal motility after reperfusion8 and the preservation of
mucosal barrier function on IR injury.9 Furthermore, NO-
releasing compounds or NO donors (e.g., SIN-1, sodium
nitroprusside, CAS 754, and FK409) exerted similar protection
against mucosal injury in rats,10 cats,11 and dogs12 as well.
Among the two calcium-dependent constitutive isoforms,
neuronal NO synthase (nNOS or type 1 NOS) is a dominant
isoenzyme in the small intestine of both rodents10 and large
animals.13 Nevertheless, the role of nNOS in intestinal IR
injuryeinduced acute inflammatory reactions is still debated.
A number of studies have demonstrated a proinflammatory
role for nNOS,14-16 but anti-inflammatory properties have also
been described.17 Furthermore, treatment with nNOS inhibi-
tor 7-nitroindazole (7-NI) in healthy rats for 4 d exhibited
higher intestinal myeloperoxidase (MPO), inducible NOS, and
nuclear factor-kappa binding activity with concomitant lower
IkBa expression.18 The paradoxical role of nNOS-mediated NO
signaling during inflammation may be due to the differences
in the severity and time course of model diseases (i.e., colitis,
sepsis, or cerebrovascular inflammation) and species differ-
ences (i.e., rodents versus larger animals) as well.
In the present study, we aimed to investigate the possible
role of nNOS in the local IPC-induced protection in the
gastrointestinal tract of a large animal model, where inner-
vation is similar to that of humans.19 To this end, 7-NI, a
specific nNOS inhibitor with a high neuronal uptake,20 was
administered before IPC in anesthetized dogs. Particular
emphasis was placed on intestinal motility function and in-
flammatory reactions in the early reperfusion phase when the
parallel involvement of NOS activation was also determined.Materials and methods
The experiments complied with the ARRIVE guidelines and
the project were approved by the National Scientific Ethics
Committee on Animal Experimentation (National Competent
Authority) in Hungary under license number V./148/2013. The
study was performed in compliance with EU Directive 2010/
63/EU on the protection of animals used for experimental and
other scientific purposes and the National Institutes of Healthtions No. 8023, revised 1978).
Surgical preparation
Outbred dogs of either sex with average body weight of
12.7  2 kg were obtained from the Animal House of the
University of Szeged (n ¼ 19). The animals were anesthetized
intravenously with sodium pentobarbital (30 mg/kg intrave-
nously), and polyethylene catheters were surgically inserted
into the femoral artery and vein to measure blood pressure
and administer fluids or drugs, respectively. All animals
received a continuous infusion of Ringer’s lactate at a rate of
10mL/kg/h during the experiments. Aftermedian laparotomy,
the root of the superiormesenteric artery (SMA) was dissected
free, and an ultrasonic flow probe (Transonic Systems Inc,
Ithaca, NY) was placed around the exposed SMA to measure
mesenteric blood flow. A branch of a tributary of the ileal vein
supplying the terminal part of the ileum was cannulated with
a 2-F polyethylene catheter to measure mesenteric venous
pressure so as to obtain blood samples (see later).
Experimental protocol
Ten male and nine female outbred dogs were randomly allo-
cated to IR (n ¼ 7; male ¼ 4 and female ¼ 3) and IPC (n ¼ 12;
male ¼ 6 and female ¼ 6) groups (Fig. 1). In the IR group,
mesenteric ischemia was elicited by occluding the SMA for
60 min with a miniclip, which was followed by 2 h of reper-
fusion. In the IPC group, animals were assigned into 7-
NIetreated or vehicle groups and were treated with the se-
lective nNOS inhibitor 7-NI (5 mg/kg; n ¼ 6; male ¼ 3 and
female¼ 3) or saline vehicle (n¼ 6; male¼ 3 and female¼ 3) in
an intravenous bolus 15 min before IPC. IPC was induced in
two groups by clamping the SMA using three cycles of 5-min
ischemia/5-min reperfusion periods starting 60 min before
IR. Stock solution of 7-NI (SigmaeAldrich Co, St. Louis, MO)
was dissolved in a mixture of 75% dimethyl sulfoxide/saline
and stored at 20C; the aliquots were diluted in 3 mL of 0.9%
saline before administration. In the IR group, animals were
treated with saline vehicle at a matching time point.
Blood samples were collected from the mesenteric vein for
later determination of plasma NOx levels at different time
points (Fig. 1). Tissue biopsies were also harvested from the
intestine for further biochemical/histologic (e.g., MPO, NOS
activity, and mast cell (MC) degranulation) analyses (at base-
line as well as at the 15th and 120th min of reperfusion).
Hemodynamic and blood gas measurements; calculation of
mucosal pH
The peripheral arterial and mesenteric venous pressures
(using Statham P23 Db transducers) were registered with a
computerized data acquisition system (Haemosys 1.17
Experimetria Ltd, Budapest, Hungary). Mesenteric vascular
resistance was calculated with a standard formula. A silastic
balloon catheter (TGS Tonomitor; Tonometrics Inc,Worcester,
MA) was introduced through a small enterotomy into the in-
testinal lumen. Arterial blood gases and intramucosal pCO2
Fig. 1 e Experimental protocol. In the first group, 60 min of ischemia was induced by occluding the SMA, which was
followed by 120 min of reperfusion (IR). In the two other groups, IR was preceded by IPC, which was elicited by inducing
three cycles of 5-min ischemia/5-min reperfusion periods in the presence and absence of a bolus injection of 7-NI (5 mg/kg)
15 min before IPC (IPCD IRD7-NI and IPCD IR groups, respectively). IR and IPCD IR groups were treated with a vehicle of 7-
NI (a mixture of 75% DMSO/saline) at corresponding time points. As indicated, blood samples from the mesenteric vein (BS)
and tissue biopsies from the affected bowel area (marked by an arrowhead) were also taken for later assessments of plasma
nitrate/nitrite levels and NOS and MPO activities, as well as to assess MC degranulation and mucosal injury.
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Intestinal pH (pHi) was calculated using the modified
HendersoneHasselbach formula with a correction factor for
30 min of equilibration.
Intestinal motility measurement
To monitor the small bowel motility, a modified strain gauge
transducer technique was applied,13 the transducers being
sutured to the circular muscle layer of a terminal ileal
segment. Motility index was calculated to estimate the
neurogenic integrity of the intestine.21
Plasma nitrate/nitrite level measurements
Plasma NOx concentrations were determined from samples
taken at baseline (t ¼ 30 min), before ischemia as well as the
15th, 60th, and 120th min of reperfusion by means of the
Griess reaction.13
Measurement of NOS enzyme activity
NOS activity was determined in intestinal tissue biopsies
based on the enzymatic conversion of 3[H]-L-arginine to 3[H]-
L-citrulline using the Lowrymethod; the Ca2 þ-dependent and
Ca2 þ-independent NOS activities were assessed in the pres-
ence and absence of Ca-calmodulin, respectively.13
Tissue MPO activity measurements
MPO, a marker of neutrophil granulocyte infiltration, was
measured from mucosal biopsies using a standard photo-
metric method.22Determination of MC degranulation
Ileal biopsies were placed into an ice-cold Carnoy’s fixative,
embedded in paraffin, sectioned (6 mm), and stained with
Alcian blue and Safranin O. Histologic analysis was performed
in coded sections by one investigator (S.V.) at 40 optical
magnification in a blinded fashion. MCs were differentiated
based on the location of granules, injury to the cell membrane,
and volume of the cytoplasm. Intact cells were characterized
by (1) intact membrane and (2) cytoplasmic granules, while
criteria for degranulated cells were specified by (1) cell mem-
brane injury, (2) reduced cytoplasmic volume and (3) loss of
cytoplasmic granules. The percentage of degranulation (MC
%) was calculated based on the number of intact MC (iMC)
and degranulated MC (dMC) mast cells: MC% ¼ dMC/
(dMC þ iMC).23
Determination of morphologic changes in the structure of
the small intestine
Analysis of morphologic injury to the same ileal biopsies was
performed on slides stained with hematoxylin-eosin in coded
slides in a blinded fashion. Measurements of the height of
different portions of the mucosa were conducted with a
computer-assisted image analysis system (IVM Pictron,
Budapest, Hungary). The extent of mucosal damage was
determined on the basis of (1) villus heightdtotal mucosal
height ratio (%) and (2) villus heightdcrypt height ratio (%);
thesewere determined for each villus of the current slide (at 3-
5 high power fields at 4magnification). Villus tip injury was
also assessed using a modified version of Chiu’s method for
each villus of the current slide (at 4-7 high power fields at 10
magnification).24
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Data analysis was performed using a statistical software
package (SigmaStat 13.0 version for Windows, Jandel Scienti-
fic, Erkrath, Germany) with nonparametric methods.
Normality was tested with the ShapiroeWilk test. Friedman’s
repeated measures analysis of variance on ranks was applied
within the groups. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences be-
tween groups were analyzed with the KruskaleWallis (one-
way analysis of variance on ranks) test, followed by Dunn’s
method for pairwise multiple comparison. Median values and
75th and 25th percentiles are illustrated in figures. Results were
considered significant at P < 0.05 value.Fig. 2 e Time course of changes in mesenteric vascular
resistance during baseline and during 60 min of SMA
occlusion followed by 120 min of reperfusion (IR group).
Further groups of animals were also subjected to IPC in the
presence and absence of 7-NI treatment (IPC D IRD7-NI
and IPC D IR groups, respectively). Here, values are
indicated as medians D 25th and 75th percentiles. Time-
dependent differences from the baseline were assessed
with Dunn’s method. Differences between groups were
analyzed with the KruskaleWallis (one-way analysis of
variance on ranks) test, followed by Dunn’s method for
pairwise multiple comparison.Results
Hemodynamic changes
Apart from an abrupt decrease during ischemia (because zero
flow and pressure during occlusion in the affected intestinal
area), no statistically significant differences between the
groups or in comparison with baseline values could be
detected in mesenteric vascular resistance (Fig. 2).
Changes in intramucosal pH
No difference in pHi values could be detected at baseline;
neither 7-NI nor IPC influenced this parameter (Fig. 3). In
response to 60 min of ischemia, however, a steep decrease in
pHi could be detected (P< 0.05) in all of the groups, which was
followed by a gradual recovery. Restoration in this parameter
appeared to be more rapid in both IPC groups as pHi values
were significantly higher than in the IR group during the 30th-
90thmin of reperfusion. At the end of reperfusion (reperfusion
120 min), pHi values were significantly higher only in the
IPC þ IR group than those in the test ischemia (IR) group.
Small bowel motility changes
Small bowel motility was not influenced by 7-NI alone or IPC
at baseline, but a transiently reducedmotility was observed in
the 7-NI-treated group immediately after the IPC procedure
(Fig. 4); this vanished in 30 min (just before the beginning of
ischemia). Ischemia alone did not induce any significant
changes in this parameter, but the early reperfusion phase
(30 min of reperfusion) was associated with an increased in-
testinal motility. This intestinal hypermotility was prevented
completely by IPC (to a similar extent in both the vehicle-
treated and 7-NIetreated groups), and at the 60th min of
reperfusion, even lowermotility values could be detected than
those seen at baseline. By the end of 2 h of reperfusion, the
motility index was normalized in all the groups.
Changes in plasma NOx levels
In the IR group, no significant changes in NOx values could be
detected at any phase of the experiments (Fig. 5). A temporary
increase was observed in the vehicle-treated IPC group inblood samples taken before the beginning of ischemia and in
both IPC groups at the beginning (at 15 min) of reperfusion.
This IPC-induced increase in NOx levels, however, was
missing in the 7-NIetreated IPC þ IR group; furthermore, a
marked increase in this parameter was seen at the last time
point (120th min) of reperfusion.
Changes in ileal NOS activities
Ca2þ-independent and Ca2þ-dependent NOS activities were
not significantly different between examined groups at base-
line (Fig. 6A and B). As for Ca2þ-independent NOS (iNOS) ac-
tivity, no statistically significant changes could be detected
throughout the entire experimental period in any of the
groups (Fig. 6B). In the IR group, Ca2þ-dependent NOS activity
showed no changes during any phase of the entire examina-
tion period either. In the vehicle-treated IPC group, however, a
marked increase in Ca2þ-dependent NOS activity was found at
the 15th min of reperfusion, but this increase was not present
in the 7-NIetreated group.
Changes in ileal MPO activity
The baseline MPO activities were similar in the different
groups (Fig. 7), but significant increases were seen at the 15th
and 120th min of reperfusion in the IR group and at the 15th
min of reperfusion in the 7-NI þ IPC þ IR groups. As compared
with the IR groups, a significant reduction in MPO activity was
evidenced in the IPC þ IR group at both examined time points
of reperfusion.
Fig. 3 e Time course of changes in intramucosal pH during
baseline and 60 min of SMA occlusion followed by 120 min
of reperfusion (IR group). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPCD IRD7-NI and IPCD IR groups,
respectively). Here, values are indicated as mediansD 25th
and 75th percentiles. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis
(one-way analysis of variance on ranks) test, followed by
Dunn’s method for pairwise multiple comparison. X
represents P<0.05 versusbaseline, and#P<0.05 versus IR.
Fig. 4 e Time course of changes in motility index during
baseline and during 60 min of SMA occlusion followed by
120 min of reperfusion (IR group). Further groups of
animals were also subjected to IPC in the presence and
absence of 7-NI treatment (IPC D IRD7-NI and IPC D IR
groups, respectively). Here, values are indicated as
medians D 25th and 75th percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s
method. Differences between groups were analyzed with
the KruskaleWallis (one-way analysis of variance on
ranks) test, followed by Dunn’s method for pairwise
multiple comparison. X represents P< 0.05 versus
baseline, and #P< 0.05 versus IR.
Fig. 5 e Time course of changes in plasma NOx during
baseline andduring 120minof reperfusionafter a 60-minof
SMA occlusion (IR group). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPCD IRD7-NI and IPCD IR groups,
respectively). Here, values are indicated as mediansD 25th
and 75th percentiles. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis
(one-way analysis of variance on ranks) test, followed by
Dunn’s method for pairwise multiple comparison. X
represents P<0.05 versusbaseline, and#P<0.05 versus IR.
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Mast cell degranulation or mucosal injury was not present at
baseline in any of the groups (Fig. 8A-D, Fig. 9A and B, Fig. 10A).
Fifteen minutes of reperfusion after a 60-min SMA occlu-
sion caused a significant increase in mast cell degranulation
(Fig. 8A, Fig. 9C and D) and mucosal injury (as evidenced by
loss of enterocyte integrity and subepithelial changes; see
details in legend for Figs. 9 and 10) and a reduction in mucosal
thickness (Fig. 8C and D) in the IR and IPC þ IRþ7-NI groups.
These changes were exacerbated only moderately by the end
of the observation period (120 min of reperfusion). In the
IPC þ IR group, however, a significantly lower extent of both
mast cell degranulation and histologic injury were observed
than in the other groups (Figs. 8 and 10C).Discussion
These data confirm the results of previous studies2,5,6,25,26 on
the protective effect of IPC in the intestine with the involve-
ment of nNOS in the IPC-induced intestinal protection
demonstrated here for the first time. The alleviating effects of
IPCweremarked by amore rapid recovery of intramucosal pH,
restored IR-induced motility changes, and reduced local in-
flammatory reaction, including leukocyte accumulation and
mast cell degranulation. As a result, IPC preserved mucosal
integrity. Compared with rodents, pigs and dogs have similar
innervation of the circular muscle layer to that of humans,19
Fig. 6 e Changes in (A) constitutive NO synthase (Ca2D-dependent NOS) and (B) inducible NO synthase (Ca2D-independent
NOS) activities in the affected ileal segment during baseline and at 15 and 120 min of reperfusion (IR). Further groups of
animals were also subjected to IPC in the presence and absence of 7-NI treatment (IPC D IRD7-NI and IPC D IR groups,
respectively). Here, plots demonstrate the median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper
whisker) percentiles. Time-dependent differences from the baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis (one-way analysis of variance on ranks) test, followed by Dunn’s
method for a pairwise multiple comparison. X represents P< 0.05 versus baseline, and #P< 0.05 versus IR.
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in a complex and detailed fashion in this large animal model.
Reperfusion injury of the bowel affects different structural
elements of the bowel in a particular sequence. The early
reperfusion phase affects the integrity of the enterocyte lining
and the rest of the mucosa relatively early, followed by injury
of themuscle and neuronal structures.27 In our study, the IPC-
induced protection of the intestinal mucosal barrier (inFig. 7 e Changes in leukocyte accumulation (MPO activity)
in the affected ileal segment during baseline and at 15 and
120 min of reperfusion (IR). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPC D IRD7-NI and IPC D IR groups,
respectively). Here, plots demonstrate the median
(horizontal line in the box) and the 25th (lower whisker)
and 75th (upper whisker) percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s
method. Differences between groups were analyzed with
the KruskaleWallis (one-way analysis of variance on
ranks) test, followed by Dunn’s method for pairwise
multiple comparison. X represents P< 0.05 versus
baseline, and #P< 0.05 versus IR.particular the villus tips) developed as early as the 15thmin of
reperfusion, which persisted over the examined 120-min
reperfusion period. A similarly early (<120 min) protective
effect was also demonstrated by others in rats as well.5,6,25
The mechanisms of protection provided by IPC in the intes-
tine were strongly linked to oxidative stress4,5,28 but were also
attributed to NO-dependent mechanisms.2,29 A transient peak
in NO release was detected during the early postischemic
phase in the rat intestine,2 and this phenomenon was also
observed if IR was preceded by IPC.30 IR has been shown to
trigger nNOS expression at the early stages of reperfusion31
even as early as 5 min of reperfusion in vitro (in Guinea
pigs)32 or after 3 h of reperfusion in vivo in the rat jejunum.31
The effect of IPC on the expression and function of nNOS
was examined here for the first time (at least to our knowl-
edge). Specifically, an nNOS-dependent NO release can be
presumed in response to IPC as levels of NOmetabolites in the
venous effluent of the intestinewere effectively reducedwhen
the specific NOS inhibitor 7-NI was administered before IPC.
At the beginning (15th min) of reperfusion, the IPC-induced
increase in Ca-dependent NOS activity was also prevented
by 7-NI. We also saw a marked increase in NOx metabolites
occurring in the late phase of reperfusion (which is rather
unexpected); this can probably be explained by nonenzymatic
production of NO33 resulting from hypoxia via impairment of
the microcirculation in the postischemic bowel tissue.
Despite the previously observed debates,14-17 the contri-
bution of nNOS to IPC-induced postischemic reactions is
obviously positive in our study. Although the role of nNOS in
the mechanisms of IPC was not examined elsewhere in the
intestine, nNOS was also found to be protective in other or-
gans, such as in heart IPC (both in vitro and in vivo).34 This
protection in the heart involves reduced oxidative/nitrosative
stress, and the positive effects of IPC are lost after nonspecific
NOS inhibition and in nNOS knockout animals.35 Here, we
could not examine the effect of nNOS inhibition on IR-induced
changes (in adherence to the 3Rs approaches in animal
research), but others also demonstrated a predominantly
Fig. 8 e Changes in (A) MC degranulation, (B) mucosal histologic injury according to Chiu’s grade, and mucosal height ([C] as
expressed as villus/crypt height ratio and [D] villus/total mucosa height ratio) in samples taken from the affected ileal
segment during baseline and at 15 and 120 min of reperfusion (IR). Further groups of animals were also subjected to IPC in
the presence and absence of 7-NI treatment (IPCD IRD7-NI and IPCD IR groups, respectively). Here, plots demonstrate the
median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper whisker) percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s method. Differences between groups were analyzed with the
KruskaleWallis (one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison.
X represents P< 0.05 versus baseline, and #P< 0.05 versus IR.
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(with respect to bowel muscle contractility and poly-
morphonuclear leukocyte accumulation).36
It appears that bowel IR may cause blood supply-
dependent and nitrosative stressemediated neuronal injury
of the bowel, but this usually occurs after relatively long
ischemic challenges (also depending on the species) and
typically develops at later stages of reperfusion.7,8,37,38 Based
on examinations of bowel motility in the present study, we
found no major sign of neurogenic dysfunction of the bowel
within the observed reperfusion period; furthermore, we
noted a temporary postischemic enhancement in this regard
at an early stage of reperfusion. On the other hand, because 7-
NI was given before IPC, we had a chance to assess its direct
effects (independently of IR). Interestingly, this manifested in
an immediate, but temporary decrease in bowel motility.
Because nNOS immunoreactive myenteric neurons are
inhibitory motoneurons and descending interneurons, the
above effect of 7-NI on bowelmotility is surprising. It is known
that NO, synthesized at a peripheral level by nNOS, reduces
intestinal motility (as was demonstrated in the sheep, for
instance)39 via sustained smooth muscle hyperpolarization;
this causes inhibition of spontaneous motility.40 On the other
hand, nonspecific inhibition of nNOS reduced gastrointestinal
motility not only in our study but also elsewhere,8,41 and wefound a similar reducing effect of 7-NI on the colon motility in
a subacute bowel obstruction model as well.13 In nNOS
knockout animals, bowel motility (after 2 h of ischemia) did
not decrease at 3 h but did so at 48 h of reperfusion,36 whereas
reduced intestinal transit time (i.e., increased motility) was
observed under similar circumstances after nNOS inhibi-
tion.41 The effects of IPC- on IR-induced bowel motility
changes were only examined in the long term, showing that
IPC restores the reducedmotility caused by 30min of ischemia
followed 6 h of reperfusion in rats.42 In our study, IPC pre-
vented the IR-induced temporary increase in bowelmotility at
the early reperfusion phase, and 7-NI had no specific effect on
this reaction within the examined time frame.
Although postischemic mucosa/enterocyte injury is
believed to be linked mostly to intracellular free radical-
mediated processes, bowel IR also induces marked inflam-
matory reactions (e.g., polymorphonuclear leukocyte accu-
mulation and MC degranulation); these can also be inhibited
by IPC.43,44 We saw simultaneous early increases in both tis-
sue MPO and MC degranulation as early as 15 min after
ischemia, which were both ameliorated by IPC. Similar, rela-
tively early MPO changes were also demonstrated in rats
(examined 30-60 min after ischemia).41,43 The nNOS de-
pendency of the latter reaction was also proven as inhibition
of nNOS (or KO)36 reversed this protection. Interestingly, the
Fig. 9 e Representative micrographs showing mucosal MCs stained with Alcian blue and Safranin O at (A and C) lower (bar
denotes 200 mm) and (B and D) higher magnifications (bar denotes 50 mm). In Panel B, please note intact intracellular
granules, whereas Panel D shows a loss of intracellular granules and stained material dispersed diffusely and
extracellularly as signs of MC degranulation at the 120th min of reperfusion in the IR group. (Color version of figure is
available online.)
Fig. 10 e Representativemicrographs of the ileal mucosa stained with hematoxylin and eosin staining at (A) baseline and (B)
120 min of reperfusion in the IR group, (C) the IPCD IR group, and (D) the IPCD IRD7-NI group. Panels B and D demonstrate
massive epithelial lifting down the side of villi, denuded villi, increased cellularity of the lamina propria, hemorrhage, and
the end of the finger-like appearance of villous structures. Panel C displays the development of subepithelial Gruenhagen’s
space at the apex of the villus, capillary congestion, and extension of the subepithelial space with a lifting of the epithelial
layer from the lamina propria. The bar denotes 200 mm in all figures.
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dependent mediator release in the small bowel.44 In our
study, however, the IR-induced degranulation of MCs was not
increased, but rather greatly prevented by IPC, which was
reversed by 7-NI. It is therefore reasonable to assume that
altered MC degranulation is a manifestation of reduced in-
flammatory reactions caused by nNOS in this IPC model, and
this process may also be involved in mediating the structural
injury of the intestinal mucosa.
Apart from oxidative injury, the integrity of the enterocyte
lining is also highly dependent on adequate oxygen delivery.
Similar to others (although working with rats),45 our study
found evidence of relatively minor IR-induced macro-
hemodynamic changes, but microvascular perfusion (as esti-
mated indirectly by tonometry) underwent a marked and
lasting deterioration. The positive effects of IPC on IR-induced
deterioration of microvascular perfusion, tissue oxygenation,
and leukocyte-endothelial interaction within the microvas-
culature of the small intestine are in evidence here and in a
number of other studies.3,46,47 These reactions were also
explained with an IPC-induced reduction of intestinal oxida-
tive stress.28 It appears that our study is the first to show that
nNOS also plays a role in a more rapid microcirculatory re-
covery after bowel IPC. Because there was also remarkably
early evidence of an increase in MPO and the appearance of
morphologic injury in the reperfusion phase in our study, the
importance of leukocyte-mediated reactions in preserving
morphologic integrity (as another manifestation of nNOS-
dependent IPC effects) cannot be ruled out either.Conclusions
In the present study, the beneficial effects of intestinal IPC
were examined in a relatively detailed fashion (with respect to
pHi, motility dysfunction, leukocyte accumulation, mast cell
degranulation, and mucosal injury). Changes in some of the
examined parameters (in particular, in IPC-induced marked
increase in NO availability: e.g., NOx and constitutive NOS
activity, pHi, inflammatory, and morphologic changes) could
be influenced/reversed by pretreatment with the nNOS in-
hibitor 7-NI. Hence, our data strongly support the contribution
of intestinal nNOS enzyme in the protective effect of IPC
against the IR-related acute inflammatory response and
morphologic injury in the small intestine.
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